Arnuity Ellipta Drug Use Investigation
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 26 Oct 2017 Status changed from not yet recruiting to recruiting.
- 06 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 31 Aug 2017.
- 15 Jun 2017 New trial record